Acceptability and usability of continuous glucose monitoring systems in older adults aged 75 years and older with diabetes Authors: Hanjin Kim, Youngran Yang, Junhee Ahn, Jeong Hee Kang Published: 2025 ABSTRACT AbstractPurposeThe purpose of this study is to explore the acceptability and usability of continuous glucose monitoring (CGM) systems as experienced by older adults aged 75 years and older with diabetes.MethodsUsing a qualitative research design, data were collected through semi-structured interviews with 14 older adults aged 75 years and older with diabetes who had no prior experience with CGM, following two weeks of CGM use. Transcripts were analyzed using a thematic qualitative analysis method to identify key statements related to participants’ experiences with CGM, with a focus on acceptability and usability.ResultsCGM was generally perceived as acceptable and useful by participants. Four key themes emerged from the analysis: Device-related burdens, barriers to CGM use, duality of CGM impact, and reflection and empowerment, along with 9 sub-themes. While CGM significantly enhanced glucose management awareness and promoted healthier lifestyle changes, it also induced psychological stress due to constant monitoring. Participants noted several barriers such as the inconvenience of carrying and charging a mobile device, complex device operations, and difficulties using educational materials due to visual impairments. The high cost of the CGM device was seen as a substantial economic barrier, underscoring the necessity for financial interventions like broader insurance coverage for individuals with type 2 diabetes.ConclusionThis study suggests that CGM may improve health outcomes for older adults aged 75 years and older with diabetes by enhancing both its acceptability and usability. It highlights the need for comprehensive technical, educational, and financial support to facilitate effective CGM usage in older adults aged 75 years and older with diabetes. Recommendations to improve usage include the adoption of wearable devices or dedicated receivers, extended battery life, user-friendly interfaces with larger fonts and clearer visual presentations, and enhanced insurance coverage.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12877-025-06575-4.Keywords: Continuous glucose monitoring, Diabetes mellitus, Aged, Patient acceptance of health care Introduction The global population aged 65 and older is projected to more than double, from 761 million in 2021 to 1.6 billion in 2050, increasing from one in ten people in 2021 to one in six by 2050 [1]. With increasing life expectancy, the prevalence of diabetes among adults aged 75 years and older is also rising, reaching 29.4% in 2022 among individuals aged 70 years and older [2]. Some scholars advocate for categorizing this group as a distinct subpopulation to facilitate tailored disease management strategies, including pharmacological interventions [3]. Compared to younger cohorts, middle-old and oldest-old adults with diabetes are at heightened risk for both microvascular and macrovascular complications, such as myocardial infarction, non-traumatic lower-limb amputations, nephropathy, and visual impairments [4, 5]. These risks underscore the necessity for comprehensive and age-specific diabetes management approaches. Self-Monitoring of Blood Glucose (SMBG), the traditional method for measuring blood glucose levels, reflects glucose concentrations only at the time of testing and lacks real-time monitoring capabilities. Consequently, it may fail to detect hypoglycemic events occurring during specific periods, such as nocturnal hypoglycemia. To address these limitations, Continuous Glucose Monitoring (CGM) systems, which enables 24-hour tracking of sensor glucose levels, have been developed and are now utilized globally [6]. The American Diabetes Association (ADA) has recently issued guidelines recommending the use of CGM for older adults with diabetes to detect and mitigate hypoglycemia [7]. CGM in older adults with diabetes is considered a viable approach for predicting and reducing the risk of hypoglycemia [8]. As evidence supporting the clinical benefits of CGM for insulin-treated individuals with type 2 diabetes continues to grow [9, 10], the 2023 Asia-Pacific Consensus Statement on CGM recommends the proactive use of CGM in frail older adults with type 2 diabetes, regardless of whether they are on oral hypoglycemic agents or insulin therapy [7]. Understanding the acceptability of innovative health technologies, such as CGM systems, is crucial for evaluating their scalability and potential for widespread implementation. Recent studies have reported mixed experiences among older adults with diabetes regarding the usability and acceptability of CGM. While some users have noted improvements in glycemic control and quality of life [11], others have expressed distress due to excessive data and frequent alarms associated with CGM use [12]. However, these studies are limited in their age coverage, often focusing on the general older adult population without distinguishing the oldest age groups. Research on the acceptability and usability of CGM among the “old” and “oldest-old” adults—namely, individuals aged 75 years and older with diabetes—is essential for effective glycemic management, prevention of complications, enhancement of self-care, and improvement of quality of life, particularly in the context of increasing life expectancy and the rise of centenarian aging. Despite its growing importance, empirical evidence focusing specifically on this demographic remains scarce [13]. Investigating the CGM-related experiences of this population can offer valuable insights into sources of user discomfort and areas for device and service improvement. Such findings may support more tailored and effective dissemination of CGM technology. Therefore, this study aims to explore the experiences of adults aged 75 years and older with diabetes regarding the use of CGM over a two-week period through a qualitative approach, with a focus on aspects of acceptability and usability. The results are intended to provide foundational data to inform patient education and counseling when considering the clinical application of CGM in this population. Methods Study design A qualitative research design was employed to explore the experiences of older adults aged 75 years and older with diabetes regarding the use of CGM. Participant eligibility and recruitment Inclusion criteria of the participants were: (1) diagnosed with type 2 diabetes for at least one year, (2) aged 75 years and older, (3) users of smartphones, (4) scored within the normal range on the Cognitive Impairment Screening Test (CIST), (5) agreed to wear a CGM device for two weeks. Exclusion criteria were: (1) prior experience with CGM use, (2) individuals with allergic skin conditions such as contact dermatitis, (3) individuals scheduled for X-ray, CT, or MRI examinations during the study period, (4) residents of long-term care facilities, 6) individuals with severe diabetes-associated complications, (5) individuals receiving home visits from healthcare professionals. Participants were recruited by posting study announcements at a university hospital, senior welfare centers, and community centers after obtaining permission from the respective administrators from December 1, 2023, to April 30, 2024. Snowball sampling also was employed. Interested individuals underwent screening, including demographic information collection and the CIST. Compatibility of their smartphones with the LibreLink app used in the study was also verified. Finally, 14 suitable participants were selected and provided informed consent. Continuous glucose monitoring protocol CGM was implemented using the Abbott FreeStyle Libre 2 system (Abbott Diabetes Care, Alameda, CA, USA). Each participant had a Libre 2 sensor applied by a researcher to the back of the upper arm using an applicator after skin cleansing. Participants were provided with the FreeStyle LibreLink smartphone application to scan the sensor and view real-time glucose readings. Prior to sensor insertion, each participant received standardized education on device use, including written and verbal instructions prepared by the study team detailing how to operate the sensor and app. They were advised that the sensor is water-resistant but to take precautions with water exposure – for example, avoiding prolonged submersion in water and gently pat-drying the area after showers. Medical-grade adhesive tape was supplied, and participants were shown how to apply it over the sensor’s edges to reinforce adhesion during activities like bathing or exercise. Each participant wore the CGM sensor continuously for 14 days. Throughout this period, the research team provided support as needed: participants had contact information to report any device issues or ask questions, and the team conducted check-ins to address potential concerns. At the end of the two-week period, sensors were removed either by the participants (following provided instructions for safe removal) or by a researcher during a final visit. Compliance with the CGM protocol was high: out of 14 older adult participants, 13 successfully completed the full 14-day monitoring period, while one participant discontinued use after approximately 9 h due to sensor-related discomfort. Data collection Data were collected through individual interviews conducted after participants completed two weeks of CGM use. Specific interview questions included: “Was the use of the continuous glucose monitor comfortable?” “What efforts were required to wear and live with the CGM?” and “In what ways did using the CGM help you?” (Supplementary 1). The interview guide was refined after conducting a pilot study with two participants who met the selection criteria. Considering the advanced age of the participants, interviews were conducted at times and locations convenient for the participants, mostly in their own homes. Each interview lasted between 30 and 60 min. The participants’ facial expressions, gestures, tone of voice, and other non-verbal cues in field notes also were documented for later analysis. The researcher completed the initial transcription of each interview within 48 h, and two researchers cross-checked the transcripts for accuracy. Data analysis The transcribed interview data were analyzed using Braun and Clarke’s six-phase thematic analysis framework, a systematic qualitative method for identifying patterns of meaning across datasets [14]. This approach allowed researchers to derive insights into participants’ lived experiences with CGM technology. A total of 83 codes were generated, and these codes with similar meanings were grouped into 23 categories. For efficient data management, the qualitative data analysis software Atlas.ti ver.24 was used. Researcher reflexivity All authors have a background in nursing and possess extensive experience in conducting qualitative research, including interviewing and data analysis. Their professional expertise in diabetes care and prior engagement in qualitative methodologies ensured that they were well qualified to undertake this study. Ensuring research rigor This study ensured rigor based on credibility, auditability, fittingness, and confirmability [15]. To enhance the credibility of the research findings, interviews were recorded and transcribed, striving to interpret participants’ experiences as faithfully as possible. Next, to secure auditability, all stages and decision-making processes of the study were meticulously documented, and research data along with related documents were securely stored. To improve fittingness, the age and gender of older adult participants with diabetes were evenly distributed. To maintain confirmability, efforts were made to consciously distinguish participants’ interview data, literature review materials, and researchers’ biases to preserve objectivity. Ethical considerations Prior to conducting this study, ethics approval was obtained from the Institutional Review Board of Jeonbuk National University (JBNU. 2023-09-034-001). Voluntary written informed consent was obtained from all participants. All procedures involving human participants were performed in accordance with the ethical standards of the institutional research committee and with the Helsinki Declaration. Results Participant characteristics A total of 14 individuals participated in the study, and their characteristics are presented in Table 1. There were 6 males (43%) and 8 females (57%). The mean age was 81.5 years (standard deviation [SD] = 6.0); 9 participants (64%) were middle-old adults aged 75 to 84 years, and 5 participants (36%) were aged 85 years or older. The average duration of diabetes was 14.4 years. Eleven participants (79%) did not perform self-monitoring of blood glucose at least once daily. Only 1 participant (7%) with type 2 diabetes was using insulin in addition to oral medication, while the remaining 13 were treated with oral medication alone. Table 1General Characteristics of Study Participants (n = 14)IDGender/Age (years)EducationMarital statusCaregiver statusDuration of Illness (years)Self-blood glucose monitoringTreatment method of diabetesMonthly income(Korean 10,000 won)1M/83High school graduateMarriedNo50NoOHA100–1502M/83High school graduateMarriedYes2NoOHA≥ 2003M/75University graduateMarriedNo2NoOHA≥ 2004M/76Postgraduate schoolMarriedNo10YesOHA≥ 2005F/78Elementary school graduateMarriedYes40NoOHA50–1006F/77High school graduateMarriedYes12NoOHA150–2007F/76Elementary school graduateWidowedYes2NoOHA50–1008F/89High school graduateSingleNo10NoOHA50–1009F/75Middle school graduateWidowedNo17YesOHA150–20010F/77IlliterateWidowedYes18NoOHA50–10011M/87University graduateDivorcedYes4NoOHA100–15012F/86Elementary school graduateMarriedYes2NoOHA50–10013M/93High school graduateWidowedYes30YesInsulin, OHA100–15014F/86High school graduateWidowedYes3NoOHA100–150Abbreviations: OHA Oral Hypoglycemic Agents General Characteristics of Study Participants (n = 14) Results of qualitative data analysis Qualitative analysis of the acceptability and usability of CGM among aged 75 or older adults with diabetes identified four main themes and nine sub-themes. The main themes were ‘Device-related burdens,’ ‘Barriers to CGM use,’ ‘Duality of CGM impact,’ and ‘Reflection and empowerment.’ Table 2. Table 2Thematic Structure and Classification of Acceptability and Usability of CGM in Study ParticipantsThemeSub-themeClassificationDevice-related burdensMobile phone dependenceAcceptabilityNot user-friendlyUsabilityBarriers to CGM useBarriers to using educational materials: visual declineUsabilityCost barriersAcceptabilityDuality of CGM impactA helper, but also a monitorAcceptabilityRelief, but also stressConvenience, but also inconvenienceUsabilityReflection and empowermentRegret over past diabetes managementAcceptabilityGaining confidence and taking action Thematic Structure and Classification of Acceptability and Usability of CGM in Study Participants Theme 1. Device-related burdens Mobile phone dependence Participants reported that, prior to using the CGM, they primarily used their mobile phones for making and receiving calls. However, the CGM required them to keep their phones with them at all times in order to scan the sensor, check their sensor glucose, and monitor the phone’s battery status. Even at home, participants found themselves needing to be constantly aware of their phone’s location, which they found inconvenient and disruptive to their usual routines. “I always have to carry my phone, which is inconvenient. For example, when charging it, I have to leave it plugged in for a while. But I can’t just leave it behind. I have to take it with me until I need to check my blood sugar with the CGM, so I always have to have my phone with me. That’s inconvenient.” (Participant 4, Male, 76 years, with a 10-year history of diabetes). “What bothered me was that I always had to have my phone with me. I usually only use my phone for calls, so at home I hardly ever touch it, but to check my blood sugar, I needed it, so I kept looking for where it was.” (Participant 7, Female, 76 years, with a 2-year history of diabetes). Not user-friendly Participants reported that the CGM device was not user-friendly for older adults, presenting various usability challenges. Many noted that while they used to be able to fix things themselves when they were younger, even basic mobile phone use had become complicated with aging. Measuring sensor glucose with the CGM via a smartphone was particularly difficult due to trouble locating the correct scanning position and the complexity of entering information such as diet, exercise, and insulin dosage into the app. Although initial instructions made the device seem straightforward, participants found it frustrating to independently measure sensor glucose, check results in the app, and review previous glucose records. Some suggested that adding voice recognition features could make the device more accessible for older adults, allowing them to navigate and use the system more easily. “It’s a bit difficult for older people to record everything in detail. You have to really understand the program and enter all the information, but for older people, even just looking at it and knowing what to input is not that easy. If you’re 80 or 90 years old, you’ll be asking, ‘Where do I write what I ate for breakfast?’” (Participant 4, Male, 76 years, with a 10-year history of diabetes). “For people like me who are older, it’s hard to find everything on a smartphone. It would be much better if there was a voice recognition feature so I could just say things like, ‘Show me my average blood sugar from yesterday,’ and it would display it right away.” (Participant 13, Male, 93 years, with a 30-year history of diabetes). Theme 2. Barriers to CGM use Barriers to using educational materials: visual decline Educational materials for CGM were perceived as ineffective by participants due to age-related vision decline, including conditions such as cataracts and astigmatism. This decline in visual ability also limited their capacity to use the application effectively. Participants recommended that educational materials for older adults be designed with larger print and simplified content to better accommodate these visual impairments. “When I tried to read what was given to me, my eyesight had gotten worse and the print was so small that I had to use a magnifying glass. But I also have astigmatism, so if I look at it for even a short time, I get dizzy. The letters shake and it’s uncomfortable. Even for people without astigmatism, the print should be bigger. I really think educational materials need to be larger.” (Participant 6, Female, 77 years, with a 12-year history of diabetes). “I used to be someone who really loved reading, but as I have gotten older, when I look at the letters, they all blur together as if they were one, which makes my eyes hurt. I have also had cataract surgery.” (Participant 8, Female, 89 years, with a 10-year history of diabetes). Cost barriers Participants recognized the high cost of CGM devices as a significant barrier, especially considering that each sensor can only be used for a short period. Many expressed concerns that the recurring expense would make it difficult to use CGM continuously, despite its perceived benefits. “If it were just a little cheaper, I would wear it as easily as taking my medication-just stick it on and go about my day. I wondered if there was a way to make it that affordable. If it cost only 30,000 to 40,000 KRW for two weeks, which would be about 50,000 to 60,000 KRW per month, I would use it. But if it costs around 200,000 KRW per month, that’s a bit much for ordinary people to use regularly.” (Participant 4, Male, 76 years, with a 10-year history of diabetes). “If they tell me to buy and attach another one every two weeks, I don’t know—maybe I could buy it once or twice. But doing this long-term would be a financial burden.” (Participant 14, Female, 86 years, with a 3-year history of diabetes). Theme 3. Duality of CGM impact A helper, but also a monitor Participants described CGM as both a helpful tool for managing their blood glucose and a source of psychological ambivalence. On one hand, CGM enabled them to monitor their glucose trends, adjust their behaviors, and prevent hypoglycemic episodes—functions they valued highly. On the other hand, the device’s continuous feedback sometimes made them feel as if they were under constant surveillance, which could be both motivating and burdensome. “It seems to tell me exactly about my body’s condition. It’s like it’s supervising what I’m doing and what I’m eating. I exercise, and it’s good that I can manage my health this way.” (Participant 1, Male, 83 years, with a 50-year history of diabetes). “Sometimes I feel like I’m being checked on. The thought that ‘I’m always being monitored’ makes me a little more proactive in managing my diabetes, even if unconsciously. I try to move around more and exercise, and I try to reduce factors that raise my blood sugar.” (Participant 3, Male, 75 years, with a 2-year history of diabetes). Relief, but also stress The emotions of participants using CGM were divided into two main types. They felt psychological relief when they could immediately check their blood glucose if they experienced symptoms, and confirm whether they were experiencing hypoglycemia. On the other hand, they also experienced stress from becoming aware of abnormal blood glucose levels that they would not have noticed otherwise, and from the pressure to lower their blood glucose, which led to avoiding foods they wanted to eat. “I checked it frequently, and every time I checked, it was reassuring, and I felt at ease in my heart. I think people with diabetes would feel psychologically very stable using this. Sometimes I wonder if I have low blood sugar, but with this, I don’t have to worry about that. That’s why I felt so much more at ease.” (Participant 11, Male, 87 years, with a 4-year history of diabetes). “I have to be careful about what I eat, and that’s stressful. If I don’t know, I just go on with my life. But because I keep checking and see that my blood sugar is high, I get stressed and can’t eat what I want.” (Participant 9, Female, 75 years, with a 17-year history of diabetes). Convenience, but also inconvenience Participants noted that while traditional blood glucose meters required multiple steps and were inconvenient, CGM allowed them to easily check their sensor glucose in real time and was more convenient to use. However, they also reported minor discomfort at the site where the CGM was attached, concern about avoiding strong impacts to the device, physical discomfort such as soreness when the device was pressed during sleep, and worry about the sensor coming off during bathing. “With self-monitoring of blood glucose, you have to prick your finger, draw blood, apply it, and check the numbers, but with this, you just scan and the result appears, so it’s easy and convenient.” (Participant 6, Female, 77 years, with a 12-year history of diabetes). “There was some discomfort. I was always aware of the device here, worried about bumping it, and if it touched something, it felt a bit strange. I was told not to do strenuous exercise, so I moved carefully, but even with a lot of movement it felt a bit awkward. Sometimes when sleeping, it would get pressed and feel sore, and even when still, I sometimes felt a dull ache.” (Participant 3, Male, 75 years, with a 2-year history of diabetes). Theme 4. Reflection and empowerment Regret over past diabetes management Participants expressed regret over their past approach to diabetes management, noting that they had not recognized the seriousness of the disease in its early stages. Many described a lack of awareness and knowledge about diabetes, which led to indifference and poor self-care. They reflected that, had they known about CGM earlier, they might have been more proactive in managing their condition. “If I had known about CGM earlier, I might have been more proactive. What I regret now is that I didn’t know at all; I had no sense about diabetes. I just thought it would be okay, but it wasn’t. I realized I have to manage it and practice it; only then can I get better. Otherwise, I can never overcome it.” (Participant 1, Male, 83 years, with a 50-year history of diabetes). “When I was first diagnosed with diabetes, I thought it was nothing serious since so many people get it. I hardly ever checked my blood glucose, and honestly, I didn’t really know what I was supposed to do. But after using this, I realized how much my glucose levels rise and fall, and I hadn’t known they were so difficult to control. If I had known earlier, I would have paid much more attention.” (Participant 14, Female, 86 years, with a 3-year history of diabetes). “I pretty much went through my 60 s and 70 s thinking diabetes wasn’t a big deal. I didn’t really know how to take care of myself, so when I ended up with diabetes, I felt it would’ve been nice to have some kind of structured guidance on how to manage it. I didn’t even know devices like CGM existed” (Participant 13, Male, 93 years, with a 30-year history of diabetes). Gaining confidence and taking action After using CGM, participants reported a significant increase in their understanding of blood glucose trends and a newfound ability to respond promptly them. This enhanced awareness fostered a sense of confidence and pride in their ability to manage their health. Many described positive behavioral changes, such as making healthier food choices and engaging in regular physical activity, even if it required giving up foods they enjoyed or adopting new routines. They viewed these sacrifices as worthwhile investments in their long-term health and well-being. “I feel a sense of pride now-I know that if I manage my health this way, I’ll get better, and if I don’t, I’ll get worse, so I feel motivated to exercise. I think if I keep managing well, I can live healthily even to 90 or 100 years old.” (Participant 1, Male, 83 years, with a 50-year history of diabetes). “I used to eat a lot of sweets. But after using this, I became more cautious. If I ate something and thought, ‘My blood sugar will probably go up,’ I would check after an hour and see that it had indeed gone up. That’s why I like it-I definitely eat fewer sweets now.” (Participant 11, Male, 87 years, with a 4-year history of diabetes). Discussion This qualitative study aimed to explore the experiences of aged 75 and older with diabetes in terms of the acceptability and usability of CGM over a two-week period. Four primary themes emerged: (1) device-related burdens (e.g., mobile phone dependence, not user-friendly), (2) barriers to CGM use (e.g., inaccessible educational materials, cost), (3) duality of CGM impact (e.g., perceived as both a helper and a monitor), and (4) reflection and empowerment (e.g., regret about past diabetes management, newfound confidence). Participants reported high acceptability of CGM for improving glycemic awareness but highlighted significant usability barriers, particularly related to device complexity and age constraints. These findings align with recent studies emphasizing the dual role of CGM as both empowering and burdensome for older adults [11, 16]. The mobile dependence described by participants resonates with broader concerns about technology integration among older adults. Participants reported the burden of having to always carry a mobile phone, monitor its battery status, and maintain connectivity to use CGM. While some CGM systems (e.g., FreeStyle Libre 2 and Dexcom G6/G7) offer handheld readers or receivers, many widely used devices—including FreeStyle Libre 3 and Medtronic Guardian Connect—require a compatible smartphone app [17]. It notes that smartphone-dependent CGM systems disproportionately burden older adults with limited digital literacy, a finding corroborated in this study. Alternatives such as wearable receivers (e.g., smartwatches) or dedicated handheld devices should be considered to reduce this barrier. Participants reported that age-related vision decline and reduced dexterity made logging activities into the CGM app increasingly difficult, while smartphone navigation became complex. To optimize CGM adaptation in adults aged 75 and older, age-friendly design principles must prioritize intuitive accessibility and cognitive compatibility. Simplified operation manuals, featuring step-by-step visual guides for scanning and activity logging, should accommodate sensory limitations. Similarly, glucose trend interpretation tools (e.g., time-in-range [TIR], glucose management indicator [GMI]) require redesigns that align with older adults’ information-processing capacities, such as large-print dashboards with high-contrast visuals and audio summaries of glucose indices. Additionally, redesigned interfaces featuring intuitive input methods (e.g., voice commands for logging food types/portions, exercise duration) and enhanced visualization tools (e.g., color-coded glucose graphs, enlarged fonts) could reduce usability barriers and empower users to engage proactively with their health data [18–20]. Developing protocols for family members such as spouses or children to assist with CGM data interpretation can reduce patient burden too. Cost emerged as a significant barrier to the acceptance of CGM among participants. In a study assessing the acceptability and usability of CGM in individuals aged 65 and older, participants expressed concerns about the high costs associated with CGM devices, particularly when not covered by insurance [11]. The annual management cost for traditional self-monitoring of blood glucose (SMBG) ranges from approximately $100 USD to $200 USD, whereas CGM systems can cost around $4,000 USD annually, representing a 22 to 48-fold increase. This substantial cost difference poses a significant economic burden for older adults. Currently, in South Korea, insurance reimbursement for CGM is limited to individuals with type 1 diabetes. In contrast, countries like the United States, the United Kingdom, and Germany have extended insurance coverage for CGM to include people with type 2 diabetes [7]. Given the higher prevalence of type 2 diabetes among older adults, the lack of insurance support in South Korea makes it challenging for this population to access CGM technology. Therefore, there is a pressing need for governmental discussions to consider expanding economic support, such as insurance reimbursement, to include people with type 2 diabetes in South Korea [21]. The revealed duality of CGM use carries significant implications. Participants perceived CGM simultaneously as a helper and a monitor, a source of relief and stress, and a means of convenience and inconvenience. This means that while CGM plays a role in reminding users of the need for blood glucose management through real-time monitoring, it can also trigger negative reactions due to the sense of being constantly watched and managed. CGM enables users to track sensor glucose variability in real time, raising awareness of diabetes management and promoting more proactive health behaviors [22, 23]. Previous studies in adults aged 65 and older have similarly reported that CGM use enhances feelings of security [24], psychological reassurance and increased autonomy in blood glucose management [25]. However, the continuous data updates and real-time monitoring of CGM can create psychological burdens for users such as stress. The continuous data updates from CGM can impose psychological burdens on some users [26]. Therefore, to maximize the positive effects of CGM use and minimize emotional burdens, it may be beneficial to provide counseling services to help manage CGM-related stress, offer positive feedback when blood glucose is stable, and establish support networks among CGM users. In terms of reflection, participants expressed regret for having been indifferent in the past due to a lack of knowledge about diabetes and insufficient awareness of the importance of blood glucose management before using CGM. Diabetes is a chronic disease accompanied by various complications, and knowledge and management are essential [27]. Knowledge about this disease can play a significant role in reducing diabetes-related complications and improving its prevention [28, 29]. Diabetes education and awareness programs tailored for adults aged 75 and older are essential. Conversely, gaining confidence through real-time glucose data mirrors findings. CGM enables real-time awareness of glucose variability, which has been shown to support improvements in dietary control and lifestyle habits [30]. This suggests that the perceived effectiveness of such interventions can positively influence acceptability. Increased self-efficacy through CGM use is recognized as a key factor in diabetes management, empowering patients to take a more active role in their own health [31]. Recent studies confirm that self-efficacy is a strong psychosocial predictor of diabetes self-management in older adults, and interventions that increase self-efficacy, such as real time feedback from CGM-can improve adherence and health behaviors [3, 32]. Tailored supportive strategies that build confidence are recommended to maximize CGM acceptance and sustained use in this population [33]. The American Diabetes Association emphasizes that structured lifestyle modifications—including dietary adjustments and increased physical activity—are foundational to achieving sustained glycemic control and long-term health outcomes in diabetes management (ADA, 2023) [34]. Emerging evidence further highlights CGM’s role in motivating such behavioral changes: 87% of users report altering food choices based on glucose feedback, while 49% increase exercise frequency to optimize time-in-range targets [35]. By providing real-time, actionable insights, CGM acts as a catalyst for sustainable self-management, bridging the gap between clinical guidance and daily practice. As the first study in Korea to apply CGM for two weeks and explore the experiences of adults aged 75 and older with diabetes, this research provides valuable insights for diabetes management in a population with a high disease prevalence. By conducting an in-depth qualitative analysis of CGM experiences among older adults, this study establishes a practical foundation for the development of future digital healthcare solutions tailored to this demographic. However, the study’s two-week intervention limits the ability to assess long-term effects and sustained user experiences. Future research should therefore examine the impact of extended CGM use and evaluate the effectiveness of comprehensive diabetes management systems that integrate CGM with other digital health technologies, such as smartphone applications and remote monitoring platforms. Pursuing these research directions will help maximize the acceptability and usability of CGM among older adults with diabetes, ultimately supporting improved health management and quality of life in this growing population. Conclusion This study applied CGM for two weeks to adults aged 75 and older with diabetes and analyzed their experiences of acceptability and usability. The findings highlight that while CGM can empower adults aged 75 and older through enhanced glucose awareness and self-management, several acceptability and usability barriers remain. To improve CGM usability, the introduction of wearable devices or dedicated receivers, extended battery life, user-friendly interfaces with large and clear visual displays, and expanded insurance coverage for type 2 diabetes treatment are needed. While CGM offers the advantage of real-time monitoring of sensor glucose variability, it can also impose psychological burdens due to continuous monitoring; thus, measures to alleviate psychological stress during CGM use are necessary. Participants reported gaining confidence from being able to directly observe and manage their blood glucose changes through CGM, which served as an important factor in enhancing self-efficacy. Since self-efficacy plays a key role in improving adherence to CGM, support that fosters user confidence is essential. The results of this study are expected to help adults aged 75 and older with diabetes establish effective blood glucose management strategies and improve their quality of life through CGM use. Supplementary Information Supplementary Material 1. Acknowledgements The authors thank all the interviewees who participated in this study. Authors’ contributions H.K. and Y.Y. co-designed the study. H.K. conducted the interviews. H.K., Y.Y., J.A., and J.K. contributed to the analysis of the findings. H.K. and Y.Y. drafted and wrote the manuscript. All authors read and approved the final version of the manuscript. Funding This research was supported by the Ministry of Education of the Republic and the National Research Foundation of Korea (NRF) 2021. (grant # no. 2021R1A2C2092656) This manuscript is a condensed form of the first author’s master’s thesis from Jeonbuk National University, Year of 2024. Data availability The data generated and/or analyzed during the study are not publicly available. Declarations Ethics approval and consent to participate Institutional Review Board of Jeonbuk National University (JBNU. 2023-09-034-001). Informed written consents were provided throughout the study. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement The data generated and/or analyzed during the study are not publicly available.